Simcere Pharmaceutical Cash Flow Statement

2096 HK$8.03 -0.1 -1.1%

7:59am

Highly Speculative, Mid Cap, Style Neutral

Market Cap £1.96bn

Enterprise Value £2.32bn

Revenue £506.0m

Quality

Value

Momentum

StockRank™

To unlock Simcere Pharmaceutical's cashflow statement please upgrade your membership.

	2017	2018	2019
Period End:	2017-12-31	2018-12-31	2019-12-31
Period Length:	12M	12M	12M
Currency:	CNY	CNY	CNY

Net Income/Starting Line

Depreciation/Depletion
Amortization
Non-Cash Items
Unusual Items
Equity in Net Earnings (Loss)
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Other Assets
Accounts Payable
Other Liabilities
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Other Investing Cash Flow Items, Total
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.